Updated on 28 September 2026
Health technology assessment: from evidence to adoption
Life Science Project Manager at Italbiotec Srl
Milan, Italy
About
We carry out health technology assessments that bring together clinical effectiveness, safety, the economic dimension and the ethical, legal, organisational and social implications. We also apply HTA at an early stage, to guide the development of a technology while choices can still be changed and to identify the evidence needed for reimbursement and adoption. The results feed into scientific publications, project deliverables and the dialogue with decision-makers and healthcare systems.
What you get: an HTA report with a synthesis of the evidence, a multidimensional assessment and recommendations on the adoption pathway, usable in publications and project deliverables and in support of reimbursement negotiations within the Italian National Health Service.
Organisation
Similar opportunities
Service
Market Access, HTA & Regulatory Strategy for Pharma and Biotech in Italy and Europe
- Other
- Consulting
- Innovation management
Alessandro Monaco
Managing director and CFO at Oliba Healthcare and Pharma
Roma, Italy
Project cooperation
Repertor.IO: Patient Preference evidence & Healthcare collaboration
- Market Access
- Capital contribution
- Strategic Partnership
Martina Di Blasio
CEO, Co-founder at Repertor․IO
TORINO, Italy
Service
NAM and MedTech Strategy, Biomedical Business Support and Project Delivery
- Other
- Marketing
- Consulting
- Technology Transfer
- Innovation management
- Research & Development
- Supply chain management
- Education, Training & Qualifying
Marco Straccia
Managing Director at FRESCI by SCIENCE&STRATEGY SL
Terrassa, Spain